In vitro genotoxicity assessment of a novel resveratrol analogue, HS-1793

Toxicological Research

Volumn 30, Issue 3, 2014, Pages 211-220

  Jeong, Min Ho ^a   Yang, Kwangmo ^b   Lee, Chang Geun ^b   Jeong, Dong Hyeok ^b   Park, You Soo ^b   Choi, Yoo Jin ^b   Kim, Joong Sun ^b   Oh, Su Jung ^b   Jeong, Soo Kyung ^b   Jo, Wol Soon ^b  

^a Dong A University College of Medicine   (South Korea)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

Bacterial mutation assay; Chromosomal aberration assay; Comet assay; Genotoxicity; HS 1793; Resveratrol

Indexed keywords

BACTERIA (MICROORGANISMS); CRICETULUS GRISEUS;

EID: 84920544600     PISSN: 19768257     EISSN: 22342753     Source Type: Journal    
DOI: 10.5487/TR.2014.30.3.211     Document Type: Article

References (35)

1. Gusman, J., Malonne, H. and Atassi, G. (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, 22, 1111-1117.
2. Pervaiz, S. and Holme, A.L. (2009) Resveratrol: its biologic targets and functional activity. Antioxid. Redox. Signaling, 11, 2851-2897.
3. Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S. and Takada, Y. (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res., 24, 2783-2840.
4. Park, J.W., Choi, Y.J., Suh, S.I., Baek, W.K., Suh, M.H., Jin, I.N., Min, D.S., Woo, J.H., Chang, J.S., Passaniti, A., Lee, Y.H. and Kwon, T.K. (2001) Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis, 22, 1633-1639.
5. Saiko, P., Szakmary, A., Jaeger, W. and Szekeres, T. (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat. Res., 658, 68-94.
6. Jeong, S.H., Lee, J.S., Jeong, N.Y., Kim, T.H., Yoo, K.S., Song, S., Suh, H., Kwon, T.K., Park, B.S. and Yoo, Y.H. (2009) A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells. Int. J. Oncol., 35, 1353-1360.
7. Jeong, S.H., Jo, W.S., Song, S., Suh, H., Seo, S.Y., Lee, S.H., Kwon, T.K. and Yoo, Y.H. (2009) A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Biochem. Pharmacol., 77, 1337-1347.
8. Kim, H.J., Yang, K.M., Park, Y.S., Choi, Y.J., Yun, J.H., Son, C.H., Suh, H.S., Jeong, M.H. and Jo, W.S. (2012) The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells. Int. J. Oncol., 41, 1628-1634.
9. Jeong, S.H., Song, I.S., Kim, H.K., Lee, S.R., Song, S., Suh, H., Yoon, Y.G., Yoo, Y.H., Kim, N., Rhee, B.D., Ko, K.S. and Han, J. (2012) An alogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 Cells via Inhibition of mitochondrial biogenesis bene expression. Mol. Cells, 34, 357-365.
10. Jeong, N.Y., Yoon, Y.G., Rho, J.H., Lee, J.S., Lee, S.Y., Yoo, K.S., Song, S., Suh, H., Choi, Y.H. and Yoo, Y.H. (2011) The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of BclxL. Int. J. Oncol., 38, 1597-1604.
11. Choi, Y.J., Yang, K.M., Kim, S.D., Yoo, Y.H., Lee, S.W., Seo, S.Y., Suh, H., Yee, S.T., Jeong, M.H. and Jo, W.S. (2012) Resveratrol analogue HS-1793 induces the modulation of tumorderived T cells. Exp. Ther. Med., 3, 592-598.
12. Jeong, M.H., Yang, K.M., Choi, Y.J., Kim, S.D., Yoo, Y.H., Seo, S.Y., Lee, S.H., Ryu, S.R., Lee, C.M., Suh, H.S. and Jo, W.S. (2012) Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+ CD25+ regulatory T cells in FM3A tumor bearing mice. Int. Immunopharmacol., 14, 328-333.
13. Nath, J. and Krishna, G. (1998) Safety screening of drugs in cancer therapy. Acta Haematol., 99, 138-147.
14. Madle, S., Korte, A. and Ball, R. (1987) Experience with mutagenicity testing of new drugs: view point of a regulatory agency. Mutat. Res., 182, 187-192.
15. Tennant, R.W., Spalding, J., Stasiewicz, S. and Ashby, J. (1990) Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the national toxicology program. Mutagenesis, 5, 3-14.
16. Maron, D.M. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
17. Organization for Economic Co-operation and Development (OECD). (1997) OECD guideline for testing of chemicals, no. 471,Genetic Toxicology: Bacterial Reverse Mutation Test. pp. 1-11.
18. Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
19. Kim, Y.J., Kim, M.S., Jeong, H.K. and Ryu, J.C. (2006) Genotoxicity study on Khal, a halocidin derivative, in bacterial and mammalian cells. Mol. Cell. Toxicol., 2, 151-158.
20. Organization for Economic Co-operation and Development (OECD). (1997) OECD guideline for testing of chemicals, no. 473, Genetic Toxicology: In vitro mammalian chromosome aberration test. pp. 1-16.
21. Matsuoka, A., Sofuni, T., Miyata, N. and Ishidate, M. Jr. (1991) Clastogenicity of 1-nitropyrene, dinitropyrenes, fluorine and mononitrofluorenes in cultured Chinease Hamster cells. Mutat. Res., 259, 103-110.
22. Ames, B.N., Lee, F.D. and Durston, W.E. (1973) An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc. Natl. Acad. Sci. USA, 70, 782-786.
23. Williams, L.D., Burdock, G.A., Edwards, J.A., Beck, M. and Bausch, J. (2009) Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem. Toxicol., 47, 2170-2182.
24. Kirkland, D. (1998) Chromosome aberration testing in genetic toxicology-past, present and future. Mutat. Res., 404, 173-185.
25. Buschini, A., Carboni, P., Frigerio, S., Furlini, M., Marabini, L., Monarca, S., Poli, P., Radice, S. and Rossi, C. (2004) Genotoxicity and cytotoxicity assessment in lake drinking water produced in a treatment plant. Mutagenesis, 19, 341-347.
26. Lee, M., Kwon, J. and Chung, M.K. (2003) Enhanced prediction of potential rodent carcinogenicity by utilizing comet assay and apoptotic assay in combination. Mutat. Res., 541, 9-19.
27. Hartmann, A., Agurell, E., Beevers, C., Brendler-Schwaab, S., Burlinson, B., Clay, P., Collins, A., Smith, A., Speit, G., Thybaud, V. and Tice, R.R. (2003) Recommendation for conducting the in vivo alkaline comet assay. Mutagenesis, 18, 45-51.
28. Henderson, L., Wolfreys, A., Fedyk, J., Bourner, C. and Windebank, S. (1998) The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis, 13, 89-94.
29. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C. and Pezzuto, J.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
30. Wang, D., Kreutzer D.A. and Essigmann J.M. (1998) Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res., 400, 99-115.
31. Gülçin, I. (2010) Antioxidant properties of resveratrol: A structure-activity insight. Innovative Food Sci. Emerging Technol., 11, 210-218.
32. Leonard, S.S., Xia, C., Jiang, B.H., Stinefelt, B., Klandorf, H., Harris, G.K. and Shi, X. (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 309, 1017-1026.
33. Jeong, M.H., Yang, K.M., Jeong, D.H., Lee, C.G., Oh, S.J., Jeong, S.K., Lee, K.W., Jo, Y.R. and Jo, W.S. (2014) Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 Cells. J. Radiat. Res., 55, 464-475.
34. Matsuoka, A., Furuta, A., Ozaki, M., Fukuhara, K. and Miyata, N. (2001) Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line. Mutat. Res., 494, 107-113.
35. Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K. and Miyata, N. (2002) The 4-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat. Res., 521, 29-35.